However, it seems that in addition to inflammation, SP-D plays a role in both energy metabolism and homeostasis; in this sense, results from previous studies have provided evidence that decreased systemic SP-D is associated with higher BMI in obese and T2DM subjects [10–12, 23]. This evidence concerns the gene SFTPD and type 2 diabetes mellitus.